DIANNE YOUNG: Open Payments
NPI 1528720307 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 42 payments from 10 companies in 2025. Trend: 2023 $776 · 2024 $435 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $341 |
| ABBVIE INC. | 10 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $167 |
| Neurocrine BioSciences, Inc. | 3 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Alkermes, Inc. | 3 | $52 |
| Braeburn Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: HETLIOZ, VRAYLAR, TRINTELLIX, INGREZZA, CAPLYTA, ARISTADA, FANAPT, BRIXADI.
Industry payments across FL — which companies pay providers there.
